Contact Information

MGHfC Hemophilia and Thrombosis Center

Yawkey Center for Outpatient Care
32 Fruit Street, Suite 8B
Boston, MA  02114

Phone: 617-726-2737
Fax: 617-724-0702

To schedule an appointment with a MassGeneral for Children pediatric specialist, please call 888-644-3248 or complete our online appointment form to request an appointment.

 

Physicians may call 888-644-3211 or use the online referral form and the Access & New Appointment Center will call your patient within 1 business day.

    Overview

    The Hemophilia and Thrombosis Center at MassGeneral Hospital for Children offers comprehensive evaluations and individualized care to children and adults with bleeding disorders due to hemophilia A, hemophilia B, rare clotting factor deficiencies and von Willebrand disease. We also evaluate and treat children with platelet-related bleeding disorders: ITP, thrombocytopenias due to other causes and disorders of platelet dysfunction.

    We have specialists in hematology, orthopedics and infectious diseases, in addition to hemophilia nursing and social services. We currently follow 40 children with severe, moderate and mild hemophilia, and approximately 100 children with von Willebrand disease, and have received approval by the New England Region to become an official Hemophilia Treatment Center.

    While one of the newer programs in the Boston area, our program is also one of the fastest growing, with the presence of a full-service obstetrics service at Massachusetts General Hospital, the expansion of the network of Partners-affiliated pediatricians and the presence of New England’s premier clinical coagulation laboratory.

    We also provide comprehensive care to children, adolescents and adults with complex inherited or acquired thrombotic disorders, including deep venous thrombosis, pulmonary embolism and thrombotic thrombocytopenia purpura. For children without symptoms whose parents or other close relatives have suffered a major thrombotic event, we offer evaluations of and counseling for inherited risk factors. We evaluate 30 to 40 new pediatric patients each year for thrombotic disorders.